Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
Approval is based on results from the OASIS 4 trial, which investigated semaglutide tablets 25 mg in adults…
Browsing Tag